Review: taking Pantoprazole sodium and Methimazole together


Summary

Drug interactions are reported among people who take Pantoprazole sodium and Methimazole together. This review analyzes the effectiveness and drug interactions between Pantoprazole sodium and Methimazole. It is created by eHealthMe based on reports of 116 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pantoprazole sodium and Methimazole >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pantoprazole Sodium

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pantoprazole sodium 13,386 users)

Methimazole

Methimazole has active ingredients of methimazole. It is often used in hyperthyroidism. (latest outcomes from Methimazole 1,858 users)

On Aug, 22, 2016

116 people who take Pantoprazole Sodium, Methimazole are studied.


Number of reports submitted per year:

Pantoprazole sodium and Methimazole drug interactions.

Drug effectiveness over time:

Pantoprazole Sodium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Methimazole:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Pantoprazole Sodium:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Methimazole:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Pantoprazole Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)
Methimazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • subdural haematoma
  • sepsis
  • cerebrovascular accident
  • hepatorenal syndrome
  • abdominal distension
  • abdominal pain
  • acute myocardial infarction
  • anaemia
  • bacterial infection
  • cardiac failure congestive
1 - 6 months:
  • ageusia
  • dizziness
  • hyperthyroidism
  • muscle contractions involuntary
  • blood thyroid stimulating hormone increased
  • cholecystitis chronic
  • gallbladder injury
  • hypothyroidism
  • injury
  • pain
not specified:
  • acute generalised exanthematous pustulosis
  • headache
  • dyspnoea
  • pain
  • nausea
  • anxiety
  • vomiting
  • cardiac failure congestive
  • chest pain
  • atrial fibrillation

Most common drug interactions by gender *:

female:
  • acute generalised exanthematous pustulosis
  • pain
  • nausea
  • dyspnoea
  • cardiac failure congestive
  • chest pain
  • hypothyroidism
  • vomiting
  • arthralgia
  • drug ineffective
male:
  • headache
  • abnormal behaviour
  • anxiety
  • death
  • dehydration
  • dyspnoea
  • feeling abnormal
  • increased upper airway secretion
  • pharyngeal disorder
  • shock

Most common drug interactions by age *:

20-29:
  • pain
  • abdominal pain
  • anhedonia
  • anxiety
  • cholecystitis acute
  • cholecystitis chronic
  • dyspepsia
  • emotional distress
  • gallbladder disorder
  • gallbladder injury
30-39:
  • nephrogenic fibrosing dermopathy
  • nephrogenic systemic fibrosis
  • headache
40-49:
  • acute generalised exanthematous pustulosis
  • respiratory failure
  • septic shock
  • body temperature decreased
  • pruritus
  • abdominal distension
  • abdominal pain
  • alopecia
  • amenorrhoea
  • anaemia
50-59:
  • dehydration
  • shock
  • adrenal insufficiency
  • gastrooesophageal reflux disease
  • haematoma
  • headache
  • pancreatitis
  • peritoneal haemorrhage
  • systemic inflammatory response syndrome
  • depression
60+:
  • vomiting
  • headache
  • dyspnoea
  • increased upper airway secretion
  • chest pain
  • nausea
  • anxiety
  • atrial fibrillation
  • feeling abnormal
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pantoprazole sodium and Methimazole?

Can you answer these questions?

More questions for: Pantoprazole sodium, Methimazole

You may be interested in these reviews

More reviews for: Pantoprazole sodium, Methimazole

On eHealthMe, Pantoprazole sodium (pantoprazole sodium) is often used to treat gastrooesophageal reflux disease. Methimazole (methimazole) is often used to treat hyperthyroidism. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.